Investment analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued on Monday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright boosted their target price on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.
View Our Latest Stock Report on SNES
SenesTech Trading Down 8.2 %
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- Comparing and Trading High PE Ratio Stocks
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Oilfield Leader SLB: An AI Name You Need to Know
- 5 Top Rated Dividend Stocks to Consider
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.